project id: TCGA-BRCA; case submitter id: TCGA-B6-A0X0; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.3; rna integrity number: 9.9; spectrophotometer method: UV Spec; age at index: 54; days to birth: -19802; days to death: 3945; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1942; year of death: 2006; age at diagnosis: 19802; ajcc pathologic m: M0; ajcc pathologic n: N0 (i-); ajcc pathologic stage: Stage I; ajcc pathologic t: T1c; ajcc staging system edition: 4th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C50.919; last known disease status: not reported; morphology: 8201/3; primary diagnosis: Cribriform carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 1996; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 5243; days to sample procurement: 0; initial weight: 150.0; portion submitter id: TCGA-B6-A0X0-01A-21; percent lymphocyte infiltration: 60.0; percent monocyte infiltration: 30.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent tumor cells: 60.0; percent tumor nuclei: 60.0;